MEK2 anticorps (AA 264-400) (FITC)
Aperçu rapide pour MEK2 anticorps (AA 264-400) (FITC) (ABIN6084115)
Antigène
Voir toutes MEK2 (MAP2K2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 264-400
-
Purification
- Protein G
-
Immunogène
- Recombinant Human Dual specificity mitogen-activated protein kinase kinase 2 protein (264-400AA).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.01 M PBS, pH 7.4, 0.03 % Proclin-300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Aliquot and store at -20 °C or -80 °C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
-
-
- MEK2 (MAP2K2) (Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2))
-
Autre désignation
- MAP2K2
-
ID gène
- 5605
-
UniProt
- P36507
-
Pathways
- Signalisation MAPK, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling
Antigène
-